RecruitingNCT06872463

Karolinska Schizophrenia Project

Brain Immunoactivation in Drug-Naive Patients with First Episode Schizophrenia


Sponsor

Karolinska Institutet

Enrollment

200 participants

Start Date

Jan 25, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

KaSP is a multimodal observational study with the goal of clarifying underlying mechanisms that cause psychotic disorders, such as schizophrenia. Participants with psychotic symptoms are recruited early after first contact with health care, within 4 weeks of starting anti-psychotic medication, and are compared to controls without psychiatric diagnoses on several measures.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is a long-term research project investigating the biology of first-episode psychosis — the first time someone experiences a break from reality (such as hallucinations or delusions) — and comparing participants to healthy volunteers to better understand what causes schizophrenia and related conditions. **You may be eligible if...** - You have recently been diagnosed with a first psychotic episode (schizophrenia, brief psychosis, schizoaffective disorder, or similar condition) - You have been on antipsychotic medication for less than 4 weeks - You are able to undergo brain scans and other study procedures - OR you are a healthy volunteer with no personal or immediate family history of psychotic illness **You may NOT be eligible if...** - You have a serious neurological illness, brain tumor, epilepsy, or significant brain injury - You are pregnant or breastfeeding - You meet criteria for a substance use disorder (other than nicotine) - You have had significant radiation exposure in the past year - (For healthy volunteers) You have any major psychiatric illness or a first-degree relative with a psychotic disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

SLSO Psykiatri Stockholm in collaboration w Karolinska Institutet

Stockholm, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06872463


Related Trials